Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) Revenue (2016 - 2025)

AtriCure (ATRC) has disclosed Revenue for 16 consecutive years, with $140.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Revenue rose 13.05% to $140.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $534.5 million, a 14.88% increase, with the full-year FY2025 number at $534.5 million, up 14.88% from a year prior.
  • Revenue was $140.5 million for Q4 2025 at AtriCure, up from $134.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $140.5 million in Q4 2025 to a low of $59.3 million in Q1 2021.
  • A 5-year average of $100.2 million and a median of $99.6 million in 2023 define the central range for Revenue.
  • Biggest YoY gain for Revenue was 74.84% in 2021; the steepest drop was 11.37% in 2021.
  • AtriCure's Revenue stood at $73.2 million in 2021, then grew by 20.23% to $88.0 million in 2022, then increased by 21.03% to $106.5 million in 2023, then rose by 16.64% to $124.3 million in 2024, then grew by 13.05% to $140.5 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Revenue are $140.5 million (Q4 2025), $134.3 million (Q3 2025), and $136.1 million (Q2 2025).